CY1106918T1 - Παραγωγα τυπου αρυλοξυαλκυλκαρβαμικων, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη - Google Patents
Παραγωγα τυπου αρυλοξυαλκυλκαρβαμικων, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγηInfo
- Publication number
- CY1106918T1 CY1106918T1 CY20071101288T CY071101288T CY1106918T1 CY 1106918 T1 CY1106918 T1 CY 1106918T1 CY 20071101288 T CY20071101288 T CY 20071101288T CY 071101288 T CY071101288 T CY 071101288T CY 1106918 T1 CY1106918 T1 CY 1106918T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- hydrogen atom
- alkyl group
- application
- aryloxylyclarbama
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Ένωση η οποία ανταποκρίνεται στον γενικό χημικό τύπο (Ι) στον οποίο το m αντιπροσωπεύει 0, 1, 2 ή 3 ˙ το n αντιπροσωπεύει 0, 1, 2 ή 3 ˙ το Χ αντιπροσωπεύει ένα άτομο οξυγόνου ή θείου ή μια ομάδα SO ή SO2 ˙ το R1 και το R2 αντιπροσωπεύουν, ανεξάρτητα το ένα από το άλλο, ένα άτομο υδρογόνου ή μια ομάδα C1-3 - αλκύλιο, ή το R1 και το R2 σχηματίζουν μαζί μια ομάδα - ( CH2 )p -, όπου το p αντιπροσωπεύει έναν ακέραιο αριθμό που κυμαίνεται από το 1 έως το 5 έτσι ώστε το n + p να είναι ένας ακέραιος αριθμός που να κυμαίνεται από το 2 έως το 5 ˙ το R3 αντιπροσωπεύει ένα άτομο υδρογόνου ή φθορίου ή μια ομάδα υδροξύ ή μεθύλιο ˙ το R4 αντιπροσωπεύει μια ομάδα του γενικού χημικού τύπου CHR5CONHR6 στην οποία το R5 αντιπροσωπεύει ένα άτομο υδρογόνου ή μια ομάδα C1-6 - αλκύλιο και το R6 αντιπροσωπεύει ένα άτομο υδρογόνου ή μια ομάδα C1-6 -αλκύλιο, C3 - 7 κυκλοαλκύλιο, C3 - 7 κυκλοαλκύλιο – C1-6 - αλκυλένιο ˙ το Υ αντιπροσωπεύει μια ομάδα η οποία έχει επιλεγεί κυρίως μεταξύ ενός φαινυλ, πυριδινυλ, πυριδαζινυλ, πυριμιδινυλ, πυραζινυλ, τριαζινυλ, θειαζολυλ, ναφθυλ, κινολινυλ, ισοκινολινυλ, φθαλαζινυλ, κιναζολινυλ, κινοξαλινυλ, ναφτυριδινυλ, σινολινυλ, βενζοφουρανυλ, διυδροβενζοφουρανυλ, βενζο - θειενυλ, διυδροβενζοθειενυλ, ινδολυλ, ισοϊνδολυλ, ινδολινυλ, βενζιμιδαζολυλ, βενζοξαζολυλ, βενζισοξαζολυλ, βενζοθειαζολυλ, βενζοϊσοθειαζολυλ, βενζοτριαζολυλ, βενζοξαδιαζολυλ, βενζοθειαδιαζολυλ, και η οποία ομάδα ενδεχομένως υποκαθίσταται ˙ ως βάση, άλας προσθήκης ενός οξέος, υδατικό ή διαλύτη. Εφαρμογή στην θεραπευτική αγωγή.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0400389A FR2865205B1 (fr) | 2004-01-16 | 2004-01-16 | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique |
EP05717376A EP1708994B1 (fr) | 2004-01-16 | 2005-01-07 | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106918T1 true CY1106918T1 (el) | 2012-09-26 |
Family
ID=34707893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071101288T CY1106918T1 (el) | 2004-01-16 | 2007-10-08 | Παραγωγα τυπου αρυλοξυαλκυλκαρβαμικων, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη |
Country Status (29)
Country | Link |
---|---|
US (3) | US7439257B2 (el) |
EP (1) | EP1708994B1 (el) |
JP (1) | JP4705590B2 (el) |
KR (1) | KR101171462B1 (el) |
CN (1) | CN100537534C (el) |
AR (1) | AR047384A1 (el) |
AT (1) | ATE369336T1 (el) |
AU (1) | AU2005212868B2 (el) |
BR (1) | BRPI0506918A (el) |
CA (1) | CA2552565C (el) |
CY (1) | CY1106918T1 (el) |
DE (1) | DE602005001930T2 (el) |
DK (1) | DK1708994T3 (el) |
ES (1) | ES2289701T3 (el) |
FR (1) | FR2865205B1 (el) |
HK (1) | HK1101283A1 (el) |
HR (1) | HRP20070421T3 (el) |
IL (1) | IL176769A (el) |
MA (1) | MA28343A1 (el) |
ME (1) | MEP26408A (el) |
NO (1) | NO20063681L (el) |
NZ (1) | NZ548530A (el) |
PL (1) | PL1708994T3 (el) |
PT (1) | PT1708994E (el) |
RS (1) | RS50518B (el) |
RU (1) | RU2392269C2 (el) |
TW (1) | TWI402067B (el) |
WO (1) | WO2005077898A1 (el) |
ZA (1) | ZA200605698B (el) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865205B1 (fr) * | 2004-01-16 | 2006-02-24 | Sanofi Synthelabo | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique |
FR2866884B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
FR2866888B1 (fr) * | 2004-02-26 | 2006-05-05 | Sanofi Synthelabo | Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique |
US7269708B2 (en) * | 2004-04-20 | 2007-09-11 | Rambus Inc. | Memory controller for non-homogenous memory system |
MX2007010076A (es) | 2005-02-17 | 2007-10-16 | Astellas Pharma Inc | Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo. |
US8197472B2 (en) | 2005-03-25 | 2012-06-12 | Maquet Cardiovascular, Llc | Tissue welding and cutting apparatus and method |
US7918848B2 (en) | 2005-03-25 | 2011-04-05 | Maquet Cardiovascular, Llc | Tissue welding and cutting apparatus and method |
WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
WO2008023720A1 (fr) * | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | COMPOSÉ D'URÉE OU SEL DUDIT COMPOSé |
US8748656B2 (en) | 2006-10-12 | 2014-06-10 | Bhi Limited Partnership | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
CN101657471B (zh) * | 2006-12-06 | 2013-07-03 | 史密丝克莱恩比彻姆公司 | 二环化合物及其作为抗糖尿病药的用途 |
AR067927A1 (es) * | 2007-08-15 | 2009-10-28 | Glaxo Group Ltd | Quinolinas sustituidas, composiciones y combinaciones que las comprenden y el uso de las mismas en la preparacion de un medicamento para tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio. |
JP2011500634A (ja) * | 2007-10-16 | 2011-01-06 | グラクソ グループ リミテッド | 炎症性疾患およびアレルギー性疾患の治療に用いるキノリン誘導体 |
US9968396B2 (en) | 2008-05-27 | 2018-05-15 | Maquet Cardiovascular Llc | Surgical instrument and method |
EP2285305A2 (en) | 2008-05-27 | 2011-02-23 | Maquet Cardiovascular LLC | Surgical instrument and method |
US9402680B2 (en) | 2008-05-27 | 2016-08-02 | Maquet Cardiovasular, Llc | Surgical instrument and method |
TW201044234A (en) * | 2009-06-08 | 2010-12-16 | Chunghwa Picture Tubes Ltd | Method of scanning touch panel |
US9955858B2 (en) * | 2009-08-21 | 2018-05-01 | Maquet Cardiovascular Llc | Surgical instrument and method for use |
MX2012008377A (es) * | 2010-01-20 | 2012-12-05 | Sanofi Sa | Derivados de alquil-heterociclo-carbamato, su preparacion y su uso en terapeutica. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE319445T1 (de) * | 1997-11-24 | 2006-03-15 | Scripps Research Inst | HEMMER DER ßGAP JUNCTION COMMUNICATIONß |
IL138972A0 (en) * | 1998-04-16 | 2001-11-25 | Texas Biotechnology Corp | N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
FR2816938B1 (fr) | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
WO2002087569A1 (en) * | 2001-04-27 | 2002-11-07 | Bristol-Myers Squibb Company | Bisarylimidazolyl fatty acid amide hydrolase inhibitors |
US6949574B2 (en) * | 2002-02-08 | 2005-09-27 | Bristol-Myers Squibb Company | (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
FR2843964B1 (fr) * | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
UA80841C2 (en) * | 2002-10-07 | 2007-11-12 | Univ California | Fatty acid amide hydrolase inhibitors, pharmaceutical composition (variants) and method to treat appetite disorders, glaucoma, pain, and related neurological disorders (variants) |
CA2501575A1 (en) * | 2002-10-08 | 2004-04-22 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
FR2850377B1 (fr) * | 2003-01-23 | 2009-02-20 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
FR2865205B1 (fr) * | 2004-01-16 | 2006-02-24 | Sanofi Synthelabo | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique |
-
2004
- 2004-01-16 FR FR0400389A patent/FR2865205B1/fr not_active Expired - Fee Related
-
2005
- 2005-01-07 PT PT05717376T patent/PT1708994E/pt unknown
- 2005-01-07 PL PL05717376T patent/PL1708994T3/pl unknown
- 2005-01-07 NZ NZ548530A patent/NZ548530A/en not_active IP Right Cessation
- 2005-01-07 RU RU2006129640/04A patent/RU2392269C2/ru not_active IP Right Cessation
- 2005-01-07 JP JP2006548339A patent/JP4705590B2/ja not_active Expired - Fee Related
- 2005-01-07 CA CA2552565A patent/CA2552565C/fr not_active Expired - Fee Related
- 2005-01-07 BR BRPI0506918-1A patent/BRPI0506918A/pt active Search and Examination
- 2005-01-07 CN CNB2005800050936A patent/CN100537534C/zh not_active Expired - Fee Related
- 2005-01-07 DE DE602005001930T patent/DE602005001930T2/de active Active
- 2005-01-07 DK DK05717376T patent/DK1708994T3/da active
- 2005-01-07 AT AT05717376T patent/ATE369336T1/de active
- 2005-01-07 RS RSP-2007/0371A patent/RS50518B/sr unknown
- 2005-01-07 ME MEP-264/08A patent/MEP26408A/xx unknown
- 2005-01-07 WO PCT/FR2005/000028 patent/WO2005077898A1/fr active Application Filing
- 2005-01-07 ZA ZA200605698A patent/ZA200605698B/en unknown
- 2005-01-07 ES ES05717376T patent/ES2289701T3/es active Active
- 2005-01-07 EP EP05717376A patent/EP1708994B1/fr active Active
- 2005-01-07 KR KR1020067016045A patent/KR101171462B1/ko not_active IP Right Cessation
- 2005-01-07 AU AU2005212868A patent/AU2005212868B2/en not_active Ceased
- 2005-01-11 TW TW094100762A patent/TWI402067B/zh not_active IP Right Cessation
- 2005-01-13 AR ARP050100111A patent/AR047384A1/es active IP Right Grant
-
2006
- 2006-07-10 IL IL176769A patent/IL176769A/en not_active IP Right Cessation
- 2006-07-11 US US11/456,708 patent/US7439257B2/en not_active Expired - Fee Related
- 2006-08-03 MA MA29230A patent/MA28343A1/fr unknown
- 2006-08-16 NO NO20063681A patent/NO20063681L/no not_active Application Discontinuation
-
2007
- 2007-08-23 HK HK07109186.8A patent/HK1101283A1/xx not_active IP Right Cessation
- 2007-09-13 HR HR20070421T patent/HRP20070421T3/xx unknown
- 2007-10-08 CY CY20071101288T patent/CY1106918T1/el unknown
-
2008
- 2008-08-21 US US12/195,906 patent/US7674805B2/en not_active Expired - Fee Related
-
2010
- 2010-01-21 US US12/691,384 patent/US8026258B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106918T1 (el) | Παραγωγα τυπου αρυλοξυαλκυλκαρβαμικων, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη | |
AR047817A1 (es) | Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica | |
EA200800482A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
BR0313943A (pt) | Composto benzanilida substituìdo e agente de controle de organismo nocivo | |
NO20084350L (no) | Heterocykliske amider til anvendelse som farmasoytika | |
EA200500304A1 (ru) | Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний | |
BR112015002017A2 (pt) | composto do tipo amida | |
NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
WO2007084595A3 (en) | Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors | |
PE20110995A1 (es) | DERIVADOS DE PIRROLO[3,4-e]PIRIMIDINA COMO INHIBIDORES DE PDE1 | |
HRP20050628A2 (en) | Substituted benzoyl derivatives uses as herbicides | |
WO2006047900A3 (de) | Neue topisch anwendbare wirkstoffe gegen mimische und alterabedingt falten | |
ECSP088253A (es) | Derivados de azol y tiazol y sus usos | |
ATE385419T1 (de) | Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat | |
CY1107903T1 (el) | Παραγωγα ακυλαμινοθειαζολης και η χρηση τους ως αναστολεις του βητα-αμυλοειδους | |
AR041303A1 (es) | Compuestos de piperidinil-imidazopiridina n-sustituidos como moduladores del receptor 5-ht4" | |
NO20054361D0 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte | |
CY1109300T1 (el) | Νεοι συντηγμενοι ετεροκυκλικοι δακτυλιοι και χρησεις αυτων | |
BRPI0619894B8 (pt) | composto de amina e composição farmacêutica | |
DK1585493T3 (da) | Triazinderivater som UV-absorbenter | |
TW200716196A (en) | Permanent waving agent | |
AR048001A1 (es) | Hidroxi - 6 - fenilantridinas que contienen tio con actividad inhibitoria de pde4 y composiciones farmaceuticas que las contienen para el tratamiento de trastornos respiratorios. | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
DE50206761D1 (de) | Fluorhaltige copolymere, deren herstellung und verwendung | |
DE60333546D1 (de) | PyrazoloÄ4,3-DÜpyrimidines, verfahren zur ihre herstellung und deren verwendung |